Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 10
Submit an article Journal homepage
259
Views
0
CrossRef citations to date
0
Altmetric
Articles

CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents

Anna Bögeleina Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Antje Stolzenburga Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Patrick Eiringb Department of Biotechnology and Biophysics, Biocenter, Julius-Maximilians-University Würzburg, Würzburg, GermanyView further author information
,
Katharina Lückeratha Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;c Department of Molecular and Medical Pharmacology, Ahmanson Translational Theranostic Division, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USAView further author information
,
Umair Munaward Department of Hematology and Oncology, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Rudolf Wernera Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Andreas Schirbela Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Samuel Samnicka Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyView further author information
,
Klaus Martin Kortümd Department of Hematology and Oncology, University Hospital Würzburg, Würzburg, GermanyORCID Iconhttps://orcid.org/0000-0002-7011-0286View further author information
ORCID Icon,
Markus Sauerb Department of Biotechnology and Biophysics, Biocenter, Julius-Maximilians-University Würzburg, Würzburg, GermanyView further author information
,
Constantin Lapaa Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;e Department of Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information
&
Andreas K. Bucka Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6447-0613View further author information
ORCID Icon show all
Pages 2393-2402 | Received 26 Dec 2021, Accepted 25 Apr 2022, Published online: 08 Jul 2022

References

  • Bolli N, Avet-Loiseau H, Wedge DC, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5(1):2997.
  • Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585–598.
  • Kawano Y, Moschetta M, Manier S, et al. Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev. 2015;263(1):160–172.
  • Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008;68(1):190–197.
  • Philipp-Abbrederis K, Herrmann K, Knop S, et al. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med. 2015;7(4):477–487.
  • Herrmann K, Schottelius M, Lapa C, et al. First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease. J Nucl Med. 2016;57(2):248–251.
  • Current K, Meyer C, Magyar CE, et al. Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intra-tumoral PSMA heterogeneity. Clin Cancer Res. 2020;26(12):2946–2955.
  • Lapa C, Luckerath K, Kircher S, et al. Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy. Br J Haematol. 2019;184(3):440–443.
  • Lagler C, El-Mesery M, Kübler AC, et al. The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent. PLOS One. 2017;12(10):e0185720.
  • Van De Linde S, Löschberger A, Klein T, et al. Direct stochastic optical reconstruction microscopy with standard fluorescent probes. Nat Protoc. 2011;6(7):991–1009.
  • Lapa C, Schreder M, Schirbel A, et al. [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma – comparison to [18F]FDG and laboratory values. Theranostics. 2017;7(1):205–212.
  • Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411–425.
  • Philipp-Abbrederis K, Herrmann K, Schottelius M, et al. [68Ga]Pentixafor: a novel PET tracer for imaging CXCR4 status in patients with multiple myeloma. Blood. 2014;124(21):2014–2014.
  • Sison EA, McIntyre E, Magoon D, et al. Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. Mol Cancer Res. 2013;11(9):1004–1016.
  • Lapa C, Lückerath K, Rudelius M, et al. [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer-initial experience. Oncotarget. 2016;7(8):9288–9295.
  • Buck AK, Stolzenburg A, Hanscheid H, et al. Chemokine receptor – directed imaging and therapy. Methods. 2017;130:63–71.
  • Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta. 2007;1768(4):952–963.
  • Kuznetsov AV, Margreiter R, Amberger A, et al. Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta. 2011;1813(6):1144–1152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.